MicroRNA-145 targets vascular endothelial growth factor and inhibits invasion and metastasis of oste

来源 :全国骨关节与风湿病暨第三届武汉国际骨科高峰论坛 | 被引量 : 0次 | 上传用户:yulingjie2006
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  MicroRNAs are important gene regulators that play a profound role in tumorigenesis.MicroRNA-145 (miR-145),an important member in the family of microRNAs,is under-expressed in several types of tumors and acts as a tumor suppressor.The role and probable pathway of miR-145 in osteosarcoma carcinogenesis is still unknown.In this study,we found that miR-145 was significantly under-expressed in osteosarcoma tissues,and the overexpression of miR-145 could inhibit invasion and angiopoiesis of osteosarcoma cells.Furthermore,the results showed vascular endothelial growth factor (VEGF) expression was down-regulated in osteosarcoma cells after miR-145 transfection.Based on these results,we performed the luciferase assay and verified that miR-145 could down-regulate VEGF at the translational level by partially binding to VEGF 3UTR.Therefore,it can be concluded that miR-145 can inhibit invasion and metastasis of osteosarcoma ceils.One of the mechanisms is miR-145 down-regulates VEGF expression by binding to the 3UTR of VEGF mRNA specifically.These novel findings may have extensive implications for an effective gene therapy of osteosarcoma.
其他文献
目的 应用基因工程技术构建出具有靶向治疗功能的新型TGF-β3融合蛋白LAP-MMP-mTGF-β3,并检验其诱导脂肪干细胞(adipose-derived stem cells,ADSCs)成软骨分化的可行性与靶向特异性。方法 首先,经基因重组定向克隆将人工合成的编码基质金属蛋白酶(MMP)切位点氨基酸的正、反义DNA序列插入真核表达载体pIRES-EGFP得到重组体plRES-EGFP-MMP
The prospective study was designed to investigate the clinical and radiographic effects of the new functional intervertebral cervical disc prosthesis in the treatment of patients with single-level and
Bone remodeling is tightly regulated by secreted and membrane-bound factors within the bone multicellular unit (BMU).It is well established that the osteoblasts regulate osteoclast differentiation via
会议
Previous studies have shown that novel scaffold-free self-assembled constructs can be an ideal alternative to cartilage tissue engineered based on scaffolds,which has many limitations.However,many que
会议
Background: Since Sir John Charney in early 1960s began the orthopedic revolution in joint replacement surgery,a lot of modification and evolution has undergone in the development of suitable bearing